Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance methotrexate dose-escalation trial in pediatric acute lymphoblastic leukemia
RBR-6pmfz8Phase 3Recruiting
- Sponsor
- Sociedade Brasileira de Oncologia Pediátrica
- Start
- Jan 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mercaptopurine and methotrexate in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Sociedade Brasileira de Oncologia Pediátrica. Started Jan 2010; status: recruiting.
02
Drugs
mercaptopurinemethotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on RBR-6pmfz8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6pmfz8.